2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
3
Uveal Melanoma
1
Neoplasms
1
Melanoma
1
Castration Resistant Prostate Cancer
1
Interventions
bintrafusp alfa protein, human
1
Triamcinolone Acetonide
1
TH 302
1
Specimen Handling
1
Magnetic Resonance Spectroscopy
1
Injections, Intramuscular
1
ALT-803
1
AGN 194204
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Castration Resistant Prostate Cancer
×
Injections, Intramuscular
×
Clear all
NCT07161778
2025-09-09
TRICREST
Barts & The London NHS Trust
Phase 2
Completed
55 enrolled